Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 12/20 | 0.69 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10962861 | 0.98 | MPO (0.67) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL10526958 | 0.92 | MPO (0.80) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL29566183 | 0.82 | CA12 (0.80) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL1436928 | 0.82 | CA12 (0.80) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL8940036 | 0.81 | MPO (0.65) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL25454282 | 0.80 | MPO (0.69) | MPOSLC6A4CA12CA2TSHR | |
| Hydrochloric Acid SCHEMBL31194866 | 0.80 | CA12 (0.77) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL5175768 | 0.80 | MPO (0.55) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL10965036 | 0.79 | MPO (0.62) | MPOSLC6A4CA12CA2TSHR | |
| SCHEMBL14278970 | 0.78 | MPO (0.43) | MPOSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | claimed |
| EP-0053389-B1 | PROCESS FOR PREPARING CATIONIC SURFACE ACTIVE AGENTS | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1985-04-03 | — | — | EP | claimed |
| EP-0053389-A1 | Process for preparing cationic surface active agents | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1982-06-09 | — | — | EP | claimed |
| EP-0053389-B1 | PROCESS FOR PREPARING CATIONIC SURFACE ACTIVE AGENTS | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
| US-4385184-A | QUATERNARYL AMMONIUM WITH HYDROXYPHENETHYL GROUP | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | MPO 173/4885SLC6A4 3105/4885CA12 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.